Could a Week-On, Week-Off chemo schedule improve life for colorectal cancer patients?
NCT ID NCT07215936
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 30 times
Summary
This study tests a different way of taking the chemotherapy drug capecitabine for colorectal cancer. Instead of the standard daily dosing, patients take the drug for 7 days, then take a 7-day break. The goal is to see if this schedule improves quality of life while still controlling the cancer. The study involves 100 adults with colorectal cancer who are in good overall health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Sohag university hospital
Sohag, Egypt
Conditions
Explore the condition pages connected to this study.